Antibe Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Antibe Therapeutics has a total shareholder equity of CA$25.9M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$56.4M and CA$30.4M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$24.91m |
| Equity | CA$25.94m |
| Total liabilities | CA$30.43m |
| Total assets | CA$56.36m |
Recent financial health updates
Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?
Dec 15
We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully
Mar 20Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business
Oct 16We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate
Jan 07
Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)
Jul 31Recent updates
Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?
Dec 15We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully
Mar 20Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business
Oct 16Antibe Therapeutics Inc.'s (TSE:ATE) Profit Outlook
Feb 11We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate
Jan 07Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)
Jul 31Need To Know: The Consensus Just Cut Its Antibe Therapeutics Inc. (CVE:ATE) Estimates For 2021
Jul 29Financial Position Analysis
Short Term Liabilities: ATE's short term assets (CA$28.1M) exceed its short term liabilities (CA$2.8M).
Long Term Liabilities: ATE's short term assets (CA$28.1M) exceed its long term liabilities (CA$27.6M).
Debt to Equity History and Analysis
Debt Level: ATE is debt free.
Reducing Debt: ATE has no debt compared to 5 years ago when its debt to equity ratio was 35.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ATE has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 14.9% each year.